PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIVENESS-ANALYSIS STUDIES OF TRASTUZUMAB (HERCEPTIN) IN TREATMENT OF HER2-POSITIVE BREAST CANCER
Abstract
Authors
OA Le
OA Le
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now